Eri Tsukagoshi
Kawasaki, 2109501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A CASE OF PEDIATRITIC TOXIC EPIDERMAL NECROSIS TRIGGERD BY OVER-THE-COUNTER EYE DROPS
Journal: Arerugi = [Allergy]
Published: October 13, 2025
Evaluation of anti-drug antibodies against therapeutic monoclonal antibodies and related product in Japanese patients with rheumatoid arthritis and their clinical impact.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 22, 2025
Clinical Profiles of Japanese Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 2023.
Journal: Biological & pharmaceutical bulletin
Published: January 03, 2024
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 30, 2023
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Journal: The Journal of investigative dermatology
Published: June 19, 2023
Validation of a genotyping technique for a surrogate marker of HLA-B∗58:01 for allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in the Japanese population.
Journal: Drug metabolism and pharmacokinetics
Published: November 18, 2022
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 02, 2022
Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Journal: Frontiers in medicine
Published: December 20, 2020
Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients.
Journal: The Journal of investigative dermatology
Published: July 15, 2019
The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Journal: Journal of pharmacological sciences
Published: July 12, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026